Aug 6, 2019 in News, Press Releases

Xphyto Therapeutics Commences Trading on the CSE

Vancouver, Canada (August 6, 2019) – XPhyto Therapeutics Corp. (CSE:XPHY) (“XPhyto” or the “Company”) is pleased to announce that its common shares will commence trading today on the Canadian Securities Exchange (the “CSE”) under the ticker symbol “XPHY”. “Trading on the CSE is a significant corporate milestone on our way to becoming a major player in the next wave of cannabis investment opportunities,” said Hugh Rogers, CEO of XPhyto. “With XPhyto’s recently announced German cannabis cultivation and extraction licence and its certified R&D processing and formulation capability coming online in Canada, the XPhyto team is strongly positioned to execute on its corporate strategy over the coming year.”

Media Inquiries North America
Mr. Knox Henderson
T: 604-551-2360
E: info@xphyto.com

Media Inquiries Europe
MC Services AG
Julia Hofmann, Andreas Jungfer
T: +49 89 210 228 0
E: xphyto@mc-services.eu